Aardvark Therapeutics, Inc.

Q: Jun 30 2026

Q: Mar 31 2026

FY: Dec 31 2025

Q: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

FY: Dec 31 2024

Submission of Matters to a Vote of Security Holders

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Other Events

Other Events

Results of Operations and Financial Condition

Other Events

Regulation FD Disclosure

Other Events

Other Events

Results of Operations and Financial Condition

Other Events

Results of Operations and Financial Condition

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Registration statement under Securities Act of 1933

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Prospectus Supplement with Pricing Information

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

06b

06b

06b

Definitive Proxy Statement

Preliminary Proxy Statement

Sun Nelson

Sun Nelson

Sun Nelson

Chi Jeffrey

Graf Susan E

Baynes Roy D.

Tong Victor Edward Jr

Sun Nelson

Lee Tien-Li

Jaiman Manasi

Sun Nelson

Lee Tien-Li

Jones Bryan

Lee Tien-Li

Lee Tien-Li

Tan Finian

Lee Tien-Li

Sun Nelson

Tan Finian

Lee Tien-Li

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission) (amendment)

No description available

Letter from the SEC

Draft registration statement (confidential submission)